Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qianxing Mo

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Oncotarget|November 4, 2020
A systematic review and meta-analysis of selected toxicity endpoints of alpelisibMisty Shields, Qianxing Mo, Melissa Armitage, et al.
Cancers|August 7, 2021
Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma CellsJaya Padmanabhan, Biswarup Saha, Chase Powell, et al.
Journal of Virology|December 20, 2013
Presence of viral DNA in whole-genome sequencing of brain tumor tissues from the cancer genome atlasE Susan Amirian, Melissa L Bondy, Qianxing Mo, et al.
Cancers|December 24, 2021
Integrative Analysis Identifies Multi-Omics Signatures That Drive Molecular Classification of Uveal MelanomaQianxing Mo, Lixin Wan, Michael J Schell, et al.
Biostatistics (Oxford, England)|May 26, 2017
A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics dataQianxing Mo, Ronglai Shen, Cui Guo, et al.
Biology of Reproduction|October 13, 2017
WNK lysine deficient protein kinase 1 regulates human endometrial stromal cell decidualization, proliferation, and migration in part through mitogen-activated protein kinase 7Nyssa R Adams, Yasmin M Vasquez, Qianxing Mo, et al.
Oncotarget|November 1, 2014
Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancerLi Zhang, Lisheng Deng, Fengju Chen, et al.
Oncoimmunology|February 28, 2022
Coupling the immunomodulatory properties of the HDAC6 inhibitor ACY241 with Oxaliplatin promotes robust anti-tumor response in non-small cell lung cancerArup Bag, Andrew Schultz, Saloni Bhimani, et al.
Oncology|November 27, 2023
A Cohort Study of the Antitumor Efficacy and Toxicity Profile of Alpelisib for Metastatic or Locally Advanced HR+, HER2- Breast Cancer: A Single-Institution ExperienceHumaira Sarfraz, Shahla Bari, Junmin Whiting, et al.
Brachytherapy|August 6, 2010
Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRTIsrael Deutsch, Michael J Zelefsky, Zhigang Zhang, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Oncotarget|November 4, 2020
A systematic review and meta-analysis of selected toxicity endpoints of alpelisibMisty Shields, Qianxing Mo, Melissa Armitage, et al.
Cancers|August 7, 2021
Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma CellsJaya Padmanabhan, Biswarup Saha, Chase Powell, et al.
Journal of Virology|December 20, 2013
Presence of viral DNA in whole-genome sequencing of brain tumor tissues from the cancer genome atlasE Susan Amirian, Melissa L Bondy, Qianxing Mo, et al.
Cancers|December 24, 2021
Integrative Analysis Identifies Multi-Omics Signatures That Drive Molecular Classification of Uveal MelanomaQianxing Mo, Lixin Wan, Michael J Schell, et al.
Biostatistics (Oxford, England)|May 26, 2017
A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics dataQianxing Mo, Ronglai Shen, Cui Guo, et al.
Biology of Reproduction|October 13, 2017
WNK lysine deficient protein kinase 1 regulates human endometrial stromal cell decidualization, proliferation, and migration in part through mitogen-activated protein kinase 7Nyssa R Adams, Yasmin M Vasquez, Qianxing Mo, et al.
Oncotarget|November 1, 2014
Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancerLi Zhang, Lisheng Deng, Fengju Chen, et al.
Oncoimmunology|February 28, 2022
Coupling the immunomodulatory properties of the HDAC6 inhibitor ACY241 with Oxaliplatin promotes robust anti-tumor response in non-small cell lung cancerArup Bag, Andrew Schultz, Saloni Bhimani, et al.
Oncology|November 27, 2023
A Cohort Study of the Antitumor Efficacy and Toxicity Profile of Alpelisib for Metastatic or Locally Advanced HR+, HER2- Breast Cancer: A Single-Institution ExperienceHumaira Sarfraz, Shahla Bari, Junmin Whiting, et al.
Brachytherapy|August 6, 2010
Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRTIsrael Deutsch, Michael J Zelefsky, Zhigang Zhang, et al.
Pageof 15